In addition, increased SUMOylation was also found in primary HSCs from NASH mice and patients, and we found that SUMOylation of FXR in HSCs was mainly mediated by SUMO1 at Lys122, Lys275, and Glu277. The gene discussed is SUMO1; the disease is metabolic dysfunction-associated steatohepatitis.